Clinical trial
Depression in Alzheimer's Disease-2
NCT00086138 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00086138 |
|---|---|
| Title | Depression in Alzheimer's Disease-2 |
| Official title | Depression in Alzheimer's Disease (DIADS-2) |
| Acronym | DIADS-2 |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease, Depression |
| Intervention type | Drug |
| Interventions | Sertraline (Zoloft), Placebo |
| Enrollment | 131 |
| Start date | Jul 1, 2004 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2009 |
| First posted | Jun 28, 2004 |
| Last update posted | Apr 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: